We have located links that may give you full text access.
An industry update: the latest developments in therapeutic delivery.
Therapeutic Delivery 2017 October
The present industry update covers the period 1-30 June 2017, with information sourced from company press releases, regulatory and patent agencies as well as scientific literature. The combination of drug and devices such as improved, safer injectables (see various market reports, companies Adamis and Baxter), patches (Microdermis) and (nano)carriers are moving increasingly from the R&D stage into clinical trials and toward the market. This addresses increased safety and effectiveness requirements, limiting physico-chemical properties of active ingredients, cost-effectiveness and patient comfort through ease of use. Further attention in the market is on local delivery methods (such as intraocular by Icon Bioscience, Glaukos) and the sheer infinite possibilities of nanotechnology such as LDL nanocarriers, microneedles and hydrogel cubes. Another 21st century key technology area is mobile applications (Vital Art and Science) and connected devices (SmartPill, Pop Test Devices) which are increasingly finding their way into the drug delivery field to enable, for example, closed loop monitoring of drug dosing in trials and of patients with their care providers. Not surprisingly companies are increasingly utilizing convergence to combine their diverse capabilities (Vetter Pharma/Microdermis, TXCell/Lentigen Technology).
Full text links
Related Resources
Trending Papers
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment.Clinical Research in Cardiology : Official Journal of the German Cardiac Society 2024 April 12
Proximal versus distal diuretics in congestive heart failure.Nephrology, Dialysis, Transplantation 2024 Februrary 30
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.American Journal of Hematology 2024 March 30
Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports.Mental Health Clinician 2023 October
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app